Notable Downgrades: Kohl’s Corp. (KSS), Duke Energy (DUK), Health Insurance Innovations (HIIQ), Identiv, Inc. (INVE)

Analysts at Sterne Agee CRT downgraded Kohl’s Corp. (KSS) from ‘Buy‘ to ‘Neutral‘ in a research report issued to clients on Thursday.

On valuation measures, Kohl’s Corp. stock it’s trading at a forward P/E multiple of 13.09x, and at a multiple of 15.49x this year’s estimated earnings. The t-12-month revenue at Kohl’s Corp. is $19.02 billion. KSS ‘s ROE for the same period is 14.49%.

Shares of the $13.32 billion market cap company are up 36.93% year-over-year and 22.82% year-to-date.

Kohl’s Corp., currently with a median Wall Street price target of $78.00 and a high target of $87.00, dropped $8.84 to $65.67 in recent trading.

The chart below shows where the equity has traded over the past 52-weeks.

Duke Energy Corporation (DUK) was downgraded from ‘Outperform‘ to ‘Neutral‘ at Credit Suisse (CS).

Shares have traded today between $74.35 and $75.80 with the price of the stock fluctuating between $68.81 to $89.97 over the last 52 weeks.

Duke Energy Corp. shares are currently changing hands at 18.85x this year’s forecasted earnings, compared to the industry’s 20.06x earnings multiple. Ticker has a t-12 price/sales ratio of 2.21. EPS for the same period registers at $4.00.

Shares of DUK have gained $1.02 to $75.46 in mid-day trading on Thursday, giving it a market cap of roughly $54 billion. The stock traded as high as $89.97 in January 28, 2015.

Health Insurance Innovations, Inc. (HIIQ) had its rating lowered from ‘Buy‘ to ‘Neutral‘ by analysts at BofA/Merrill (BAC) on Thursday. Currently there are 4 analysts that rate HIIQ a ‘Buy‘. No analyst rates it a ‘Sell‘ or a ‘Hold‘.

HIIQ was down $1.79 at $5.96 in mid-day trade, moving within a 52-week range of $5.30 to $14.24. The name, valued at $45.53 million, opened at $5.75.

On valuation measures, Health Insurance Innovations Inc. shares have a t-12 price/sales ratio of 0.68. EPS for the same period registers at ($0.06).

Identiv, Inc. (INVE) was reiterated as ‘Outperform’ and the price target was lowered to $14 from $21 at Northland Capital. The firm’s new price objective suggests a potential downside of 33%.

INVE shares recently lost $1.69 to $7.21. In the past 52 weeks, shares of Fremont, California-based security technology firm have traded between a low of $6.12 and a high of $21.31. Shares are up 21.92% year-over-year ; down 36% year-to-date.

Be the first to comment

Leave a Reply

Your email address will not be published.


*